Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Phillips-Van Heusen

Article Abstract:

A comparative analysis of the company sales and financial details of Phillips-Van Heusen Corp. from 1988 to 2003 are illustrated. Projections of the annual total returns, revenues and the asset position of the company for the period 2007-09 are made using value line estimates.

Author: Fung, Deborah Y.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Comparative analysis, Phillips-Van Heusen Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Oshkosh B'Gosh 'A'

Article Abstract:

A comparative analysis of the company sales and financial details of Oshkosh B'Gosh, Inc. from 1987 to 2003 are illustrated. Projections of the annual total returns, revenues and the asset position of the company for the period 2006-08 are made using value line estimates.

Author: Fung, Deborah Y.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Oshkosh B'Gosh Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Securities, Company sales and earnings, Clothing industry, Company earnings/profit, Company securities, Textile and clothing industry software
Similar abstracts:
  • Abstracts: Best state firms. The Asian experience. Comeback rail
  • Abstracts: It's hard for the money. . Still in the black. Under the carpet
  • Abstracts: Axsys Tech. Microvision Inc
  • Abstracts: Guess, Inc. Kellwood Company
  • Abstracts: Kellwood Co.. Kellwood Company
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.